Distinguished Abstract
Meeting
Search Results for GAS
Finalist
Abstract Number: 489
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Case Presentation: A 43-year-old male with roux-en-y gastric bypass fourteen years ago with complications and multiple adhesions, hiatal hernia associated with nausea and vomiting, and subsequent small bowel resection last year, started to experience cognitive changes and short-term memory loss. He has also experienced problems with balance, generalized weakness, and unintentional 60-pound weight loss. His [...]
Abstract Number: 61
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Use of Percutaneous Endoscopic Gastrostomy (PEG) tubes among patients with dementia is controversial, with multiple studies showing no clear benefit in terms of risks of aspiration, survival or quality of life. Despite this growing evidence, studies analyzing the trends of use of PEG tube among demented patients are lacking. We aimed to use a [...]
Abstract Number: H9
SHM Converge 2022
Background: Epidemiology of Non-Variceal Upper Gastrointestinal Bleeding (NVUGIB) such as peptic ulcer bleeding, Mallory-Weiss tear, erosive gastritis/duodenitis, oesophagitis/oesophageal ulcer is well known among general population. However, data is lacking about its trend among Cirrhotic population in literature. No large database study is available to compare prevalence, predictors, and outcomes of NVUGIB among Cirrhotic patients. We [...]
Abstract Number: 105
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: In Japan, a “super-aged” society, the rate of end-stage dysphagia in the elderly is increasing. Artificial hydration and nutrition (AHN) can be used for such patients, although it may not improve mortality or quality of life. The many downsides of AHN are not always well explained to patients and their families, resulting in routine [...]
Abstract Number: 119
SHM Converge 2024
Background: Hepatic artery pseudoaneurysm (HAP) is a rare entity, potentially life threatening and associated with high mortality. The aim of this study was to evaluate Mayo Clinic enterprise’s clinical experience with HAP occurrence, clinical features and outcome in the last 20 years, and to compare our results with what the literature. Methods: This retrospective analysis [...]
Abstract Number: 122
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Over the last two decades concerns have been raised about the potential risk of blood transfusion over the benefits. General restrictive red blood cell (RBC) transfusion approach for anemic hospitalized patients (thresh hold of 7 gm %) has been adopted by American hematology society (AHS) in 2012. It is important to recognize that guidelines [...]
Abstract Number: 126
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Unplanned readmissions among cancer patients are common and gastrointestinal (GI) cancer has some of the highest readmission volumes. Under the Affordable Care Act, hospitals have been getting penalized for excessive readmission rates. For now, the medical treatment of cancer is exempt from this measure. This is because the readmission profile of the cancer patient [...]
Abstract Number: 150
SHM Converge 2023
Background: A higher Helicobacter pylori (H. pylori) prevalence was associated with increased rates of post-operative complications including increased marginal ulceration and leak rates. Limited studies described prevalence of H. pylori in patients undergoing bariatric surgery and H. pylori associated upper and lower gastrointestinal bleeding (GIB). Primary Aim of our study was to evaluate the prevalence [...]
Abstract Number: 152
SHM Converge 2024
Background: Patients who are hospitalized for a prolonged period are at risk of developing various complications, includingfeeding intolerance resulting from reduced gastrointestinal motility. Prucalopride is one of the drugs used for thetreatment of constipation, and it exerts its effects by increasing intestinal motility through the activation of the 5-HT4receptor.However, no previous study demonstrated whether prucalopride [...]
Abstract Number: 158
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Widespread use of new oral anticoagulants (NOAG) for Atrial Fibrillation (A-Fib) has increased the annual incidence of gastrointestinal bleed (GIB) in recent years. These NOAG agents in our study include Rivaroxaban, Apixaban and Dabigatran. Convenience of use, quick onset, broad therapeutic window and eliminating need for frequent monitoring makes NOAGs attractive for A-Fib associated [...]